Molecular Communication-Based Intelligent Dopamine Rate Modulator for Parkinson’s Disease Treatment

Molecular Communication-Based Intelligent Dopamine Rate Modulator for Parkinson’s Disease Treatment 150 150 Transactions on NanoBioscience (TNB)

Abstract:

Parkinson’s disease (PD) is a progressive neurodegenerative disease, and it is caused by the loss of dopaminergic neurons in the basal ganglia (BG). Currently, there is no definite cure for PD, and available treatments mainly aim to alleviate its symptoms. Due to impaired neurotransmitter-based information transmission in PD, molecular …

View on IEEE Xplore